Aion Therapeutic Inc (CSE:AION) CEO, Dr Stephen Barnhill presents at Proactive's One2One virtual investor forum.
The Toronto-based group recently filed five patent applications with the US Patent and Trademark Office related to the combination of medical cannabis with edible and psychedelic mushrooms.